Krukar, K.M. et al. 2024. Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review. Journal of Education, Health and Sport. 68, (Sep. 2024), 55282. DOI:https://doi.org/10.12775/JEHS.2024.68.55282.